Kevin Ginsburg, M.D., MS, is a urologist with subspeciality training in
urologic oncology. Dr. Ginsburg has both a clinical practice and research interests in treating patients
with urologic malignancies. His clinical practice spans the spectrum of urologic oncology,
allowing him to provide comprehensive urologic oncology care to patients with a variety of
malignancies including prostate, bladder, kidney, ureteral, testicular, adrenal and penile
cancer. Dr. Ginsburg offers surgical and non-surgical treatments for patients with all urologic malignancies,
which allows him to help patients decided on the right treatment type or surgery (open,
laparoscopic, and robotic surgery) that is best for them, their family, and their goals.
Dr. Ginsburg's research interests have solidified at the intersection of urologic oncology and health services
research. These interests have involved studying the variation and patterns of how health care
is delivered and the resulting effect of this variation on clinical outcomes. He has applied this
interest to studying variation in practice patterns in patients with low and intermediate risk
prostate cancer on active surveillance, an observational strategy with the intent to avoid or
delay treatment. This research has focused on how urologists use different imaging and
genetic tools to aid in risk stratification for men with newly diagnosed prostate cancer and
how these different tools affect medical decision making and longer-term oncological
outcomes. Additionally, Dr. Ginsburg has a keen interest in quality improvement research for men with
prostate cancer. Additionally, he is the co-director of the prostate cancer program of the Michigan
Urological Surgery Improvement Collaborative (MUSIC), In this role, Dr. Ginsburg helps to direct the
quality improvement initiatives of more than 250 urologists from 46 practices across Michigan to
help achieve our goal of “to make Michigan the best place in the world for prostate cancer
care.”
Research Interests
Health services and outcomes research for urologic malignancies,
optimizing active surveillance for prostate cancer, improving prostate cancer risk stratification,
decreasing the morbidity of prostate cancer surgery and preserving functional outcomes after
prostate cancer surgery, focal therapy for prostate cancer
Clinical Interests
Surgical and non-surgical treatments for prostate, kidney, bladder,
testicular, urethral, ureteral and penile cancers. Dr. Ginsburg specializes in providing comprehensive
urologic and surgery care, which allows him to help provide the right treatment type or surgery
(open, laparoscopic, or robotic) for the right patient.